Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat

Neuroscience

Volumn 83, Issue 3, 1998, Pages 723-740

  Belluardo, N ^a,b   Blum, M ^c   Mudo, G ^a,b   Andbjer, B ^a   Fuxe, K ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CATANIA   (Italy)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Basic fibroblast growth factors; Cerebral cortex; Gene expression; Hippocampus; Nicotine; Nigrostriatal system

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; BASIC FIBROBLAST GROWTH FACTOR; DIZOCILPINE; MECAMYLAMINE; MESSENGER RNA; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DIENCEPHALON; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TELENCEPHALON;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DIENCEPHALON; FIBROBLAST GROWTH FACTOR 2; IMMUNOHISTOCHEMISTRY; NEUROPROTECTIVE AGENTS; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TELENCEPHALON; TIME FACTORS;

EID: 0032484494     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00323-0     Document Type: Article

References (78)

1. 1. Akaike A., Tamura Y., Yokota T., Shimohama S. and Kimura J. (1994) Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 644, 181-187.
2. 2. Anderson K. J., Dam D., Lee S. and Cotman C. W. (1988) Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature 332, 360-361.
3. 3. Baird A. (1994) Fibroblast growth factors: activities and significance of non-neurotrophin neurotrophic growth factors. Curr. Opin. Neurobiol. 4, 78-86.
4. 4. Ballarin M., Ernfors P., Lindefors N. and Persson H. (1991) Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain. Expl Neurol. 114, 35-43.
5. 5. Baron J. A. (1986) Cigarette smoking and Parkinson's disease. Neurology 36, 1490-1496.
6. 6. Bean A. J., Elde R., Cao Y. H., Oellig C., Tamminga C., Goldstein M., Pettersson R. F. and Hokfelt T. (1991) Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human. Proc. natn. Acad. Sci. U.S.A. 88, 10,237-10,241.
7. 7. Belluardo N., Mudò G., Dell'Albani P., Jiang X. H. and Condorelli D. F. (1995) NMDA receptor-dependent and -independent immediate early gene expression induced by focal mechanical brain injury. Neurochem. Int. 26, 443-453.
8. 8. Belluardo N., Wu G., Mudò G., Hansson A. C., Pettersson R. F. and Fuxe K. (1997) Comparative localization of fibroblast growth factor receptor 1,2, and 3 mRNAs in the rat brain. An in situ hybridization analysis. J. comp. Neurol. 379, 226-246.
9. 9. Blum M. (1989) Regulation of neuroendocrine peptide gene expression. Meth. Enzym. 168, 618-633.
10. 10. Blum M., Wu G., Mudò G., Belluardo N., Andersson K., Agnati L. F. and Fuxe K. (1996) Chronic continuous infusion of (-)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat. Neuroscience 70, 169-177.
11. 11. Chadi G., Moller A., Rosen L., Janson A. M., Agnati L. A., Goldstein M., Ogren S. O., Pettersson R. F. and Fuxe K. (1993) Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion. Expl Brain Res. 97, 145-158.
12. 12. Cheng B. and Mattson M. P. (1991) NGF and FGF-2 protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 7, 1031-1041.
13. 13. Cintra A., Cao Y. H., Oellig C., Tinner B., Bortolotti F., Goldstein M., Pettersson R. F. and Fuxe K. (1991) Basic FGF is present in dopaminergic neurons of the ventral midbrain of the rat. NeuroReport 2, 597-600.
14. 14. Clarke P. B., Schwartz R. D., Paul S. M., Pert C. B. and Pert A. (1985) Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]alpha-bungarotoxin. J. Neurosci. 5, 1307-1315.
15. 15. Decker M. W., Brioni J. D., Bannon A. W. and Arneric S. P. (1995) Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Sci. 56, 545-570.
16. 16. Dionne C. A., Crumley G., Bellot F., Kaplow J. M., Searfoss G., Ruta M., Burgess W. H., Jaye M. and Schlessinger J. (1990) Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. Eur. molec. Biol. Org. J 9, 2685-2692.
17. 17. Eckenstein F. P. (1994) Fibroblast growth factors in the nervous system. J. Neurobiol. 25, 1467-1480.
18. 18. Emoto N., Gonzalez A. M., Walicke P. A., Wada E., Simmons D. M., Shimasaki S. and Baird A. (1989) Basic fibroblast growth factor (FGF) in the central nervous system: identification of specific loci of basic FGF expression in the rat brain. Growth Factors 2, 21-29.
19. 19. Endoh M., Pulsinelli W. A. and Wagner J. A. (1994) Transient global ischemia induces dynamic changes in the expression of FGF-2 and the FGF receptor. Molec. Brain Res. 22, 76-88.
20. 20. Ernfors P., Lonnerberg P., Ayer L. L. C. and Persson H. (1990) Developmental and regional expression of basic fibroblast growth factor mRNA in the rat central nervous system. J. Neurosci. Res. 27, 10-15.
21. 21. Ferrari G., Minozzi M. C., Toffano G., Leon A. and Skaper S. D. (1989) Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Devl Biol. 133, 140-147.
22. 22. Finklestein S. P., Apostolides P. J., Caday C. G., Prosser J., Philips M. F. and Klagsbrun M. (1988) Increased basic fibroblast growth factor (FGF-2) immunoreactivity at the site of focal brain wounds. Brain Res. 460, 253-259.
23. 23. Freedman R., Wetmore C., Stromberg I., Leonard S. and Olson L. (1993) Alpha-bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression. J. Neurosci. 13, 1965-1975.
24. 24. Freese A., Finklestein S. P. and Di F. M. (1992) Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity. Brain Res. 575, 351-355.
25. 25. Fuxe K., Janson A. M., Jansson A., Andersson K., Eneroth P. and Agnati L. F. (1990) Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection. Naunyn-Schmiedeberg's Arch. Pharmac. 341, 171-181.
26. 26. Fuxe K., Tinner B., Zoli M., Pettersson R. F., Baird A., Biagini G., Chadi G. and Agnati L. F. (1996) Computer-assisted mapping of basic fibroblast growth factor immunoreactive nerve cell populations in the rat brain. J. chem. Neuroanat. 11, 13-35.
27. 27. Gall C. M., Berschauer R. and Isackson P. J. (1994) Seizures increase basic fibroblast growth factor mRNA in adult rat forebrain neurons and glia. Molec. Brain Res. 21, 190-205.
28. 28. Galzi J. L. and Changeux J. P. (1995) Neuronal nicotinic receptors: molecular organization and regulations. Neuropharmacology 34, 563-582.
29. 29. Gomez Pinilla F. and Cotman C. W. (1993) Distribution of fibroblast growth factor 5 mRNA in the rat brain: an in situ hybridization study. Brain Res. 606, 79-86.
30. 30. Gonzalez A. M., Berry M., Maher P. A., Logan A. and Baird A. (1995) A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain. Brain Res. 701, 201-226.
31. 31. Gonzalez A. M., Buscaglia M., Ong M. and Baird A. (1990) Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues. J. Cell Biol. 110, 753-765.
32. 32. Grandinetti A., Morens D. M., Reed D. and MacEachern D. (1994) Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am. J. Epidemiol. 139, 1129-1138.
33. 33. Greenberg M. E., Ziff E. B. and Greene L. A. (1986) Stimulation of neuronal acetylcholine receptors induces rapid gene transcription. Science 234, 80-83.
34. 34. Harfstrand A., Adem A., Fuxe K., Agnati L., Andersson K. and Nordberg A. (1988) Distribution of nicotinic cholinergic receptors in the rat tel- and diencephalon: a quantitative receptor autoradiographical study using [3H]acetylcholine, [alpha-125I]bungarotoxin and [3H]nicotine. Acta physiol. scand. 132, 1-14.
35. 35. Janson A. M., Fuxe K., Agnati L. F., Kitayama I., Harfstrand A., Andersson K. and Goldstein M. (1988) Chronic nicotine treatment counteracts the disappearance of tyrosine hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection. Brain Res. 455, 332-345.
36. 36. Janson A. M., Fuxe K., Agnati L. F., Sundsrom E. and Goldstein M. (1991) The effect of chronic nicotine treatment on 1-methyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. In Effects of Nicotine on Biological Systems (ed. Adlkofer F. K. T.), pp. 323. Birkhauser Verlag, Basel.
37. 37. Janson A. M., Fuxe K. and Goldstein M. (1992) Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse. Clin. Invest. 70, 232-238.
38. 38. Janson A. M., Fuxe K., Sundstrom E., Agnati L. F. and Goldstein M. (1988) Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. Acta physiol. scand. 132, 589-591.
39. 39. Janson A. M. and Moller A. (1993) Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat. Neuroscience 57, 931-941.
40. 40. Johnson D. E. and Williams L. T. (1993) Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res 60, 1-41.
41. 41. Keegan K., Johnson D. E., Williams L. T. and Hayman M. J. (1991) Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc. natn. Acad. Sci. U.S.A. 88, 1095-1099.
42. 42. Kiefer M. C., Stephans J. C., Crawford K., Okino K. and Barr P. J. (1990) Ligand-affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor. Proc. natn. Acad. Sci. U.S.A. 87, 6985-6989.
43. 43. Kiyota Y., Takami K., Iwane M., Shino A., Miyamoto M., Tsukuda R. and Nagaoka A. (1991) Increase in basic fibroblast growth factor-like immunoreactivity in rat brain after forebrain ischemia. Brain Res. 545, 322-328.
44. 44. Kley N., Loeffler J. P., Pittius C. W. and Hollt V. (1987) Involvement of ion channels in the induction of proenkephalin A gene expression by nicotine and cAMP in bovine chromaffin cells. J. biol. Chem. 262, 4083-4089.
45. 45. Knusel B., Michel P. P., Schwaber J. S. and Hefti F. (1990) Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J. Neurosci. 10, 558-570.
46. 46. Kurokawa T., Seno M. and Igarashi K. (1988) Nucleotide sequence of rat basic fibroblast growth factor cDNA. Nucl. Acids Res. 16, 5201.
47. 47. Lee P. L., Johnson D. E., Cousens L. S., Fried V. A. and Williams L. T. (1989) Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science 245, 57-60.
48. 48. Levin E. D. (1992) Nicotinic systems and cognitive function. Psychopharmacology 108, 417-431.
49. 49. Lippoldt A., Andbjer B., Rosen L., Richter E., Ganten D., Cao Y., Pettersson R. F. and Fuxe K. (1993) Photochemically induced focal cerebral ischemia in rat: time dependent and global increase in expression of basic fibroblast growth factor mRNA. Brain Res. 625, 45-56.
50. 50. Matsuzaki K., Yoshitake Y., Matuo Y., Sasaki H. and Nishikawa K. (1989) Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc. natn. Acad. Sci. U.S.A. 86, 9911-9915.
51. 51. Mattson M. P., Murrain M., Guthrie P. B. and Kater S. B. (1989) Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. 9, 3728-3740.
52. 52. Morrison R. S., Sharma A., de V. J. and Bradshaw R. A. (1986) Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc. natn. Acad. Sci. U.S.A. 83, 7537-7541.
53. 53. Nakata N., Kato H. and Kogure K. (1993) Protective effects of basic fibroblast growth factor against hippocampal neuronal damage following cerebral ischemia in the gerbil. Brain Res. 605, 354-356.
54. 54. Ornitz D. M. and Leder P. (1992) Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J. biol. Chem. 267, 16305-16311.
55. 55. Orr-Urtreger A., Givol D., Yayon A., Yarden Y. and Lonai P. (1991) Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development 113, 1419-1434.
56. 56. Otto D. and Unsicker K. (1990) Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J. Neurosci. 10, 1912-1921.
57. 57. Pang Y., Kiba H. and Jayaraman A. (1993) Acute nicotine injections induce c-fos mostly in non-dopaminergic neurons of the midbrain of the rat. Molec. Brain Res. 20, 162-170.
58. 58. Partanen J., Makela T. P., Eerola E., Korhonen J., Hirvonen H., Claesson W. L. and Alitalo K. (1991) FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. Eur. molec. Biol. Org. J. 10, 1347-1354.
59. 59. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
60. 60. Peters K., Ornitz D., Werner S. and Williams L. (1993) Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Devl Biol. 155, 423-430.
61. 61. Raz V., Kelman Z., Avivi A., Neufeld G., Givol D. and Yarden Y. (1991) PCR-based identification of new receptors: molecular cloning of a receptor for fibroblast growth factors. Oncogene 6, 753-760.
62. 62. Riva M. A., Gale K. and Mocchetti I. (1992) Basic fibroblast growth factor mRNA increase in specific brain regions following convulsive seizures. Molec. Brain Res. 15, 311-318.
63. 63. Safran A., Avivi A., Orr U. A., Neufeld G., Lonai P., Givol D. and Yarden Y. (1990) The murine flg gene encodes a receptor for fibroblast growth factor. Oncogene 5, 635-643.
64. 64. Schulz D. W., Loring R. H., Aizenman E. and Zigmond R. E. (1991) Autoradiographic localization of putative nicotinic receptors in the rat brain using 125I-neuronal bungarotoxin. J. Neurosci. 11, 287-297.
65. 65. Shimasaki S., Emoto N., Koba A., Mercado M., Shibata F., Cooksey K., Baird A. and Ling N. (1988) Complementary DNA cloning and sequencing of rat ovarian basic fibroblast growth factor and tissue distribution study of its mRNA. Biochem. biophys. Res. Commun. 157, 256-263.
66. 66. Tagashira S., Ozaki K., Ohta M. and Itoh N. (1995) Localization of fibroblast growth factor-9 mRNA in the rat brain. Molec. Brain Res. 30, 233-241.
67. 67. Timmusk T., Belluardo N., Metsis M. and Persson H. (1993) Widespread and developmentally regulated expression of neurotrophin-4 mRNA in rat brain and peripheral tissues. Eur. J. Neurosci. 5, 605-613.
68. 68. van der Wal E. A., Gomez-Pinilla F. and Cotman C. W. (1994) Seizure-associated induction of basic fibroblast growth factor and its receptor in the rat brain. Neuroscience 60, 311-323.
69. 69. Vidal C. and Changeux J. P. (1993) Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro. Neuroscience 56, 23-32.
70. 70. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J. and Swanson L. W. (1989) Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. comp. Neurol. 284, 314-335.
71. 71. Walicke P., Cowan W. M., Ueno N., Baird A. and Guillemin R. (1986) Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc. natn. Acad. Sci. U.S.A. 83, 3012-3016.
72. 72. Walicke P. A. (1988) Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions. J. Neurosci. 8, 2618-2627.
73. 73. Wanaka A., Johnson E. J. and Milbrandt J. (1990) Localization of FGF receptor mRNA in the adult rat central nervous system by in situ hybridization. Neuron 5, 267-281.
74. 74. Wang X., Bacher B. and Hollt V. (1994) Nicotine-induced gene expression of proenkephalin in bovine chromaffin cells. Clin. Invest. 72, 925-929.
75. 75. Wetmore C., Ernfors P., Persson H. and Olson L. (1990) Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization. Expl Neurol. 109, 141-152.
76. 76. Wilcox B. J. and Unnerstall J. R. (1991) Expression of acidic fibroblast growth factor mRNA in the developing and adult rat brain. Neuron 6, 397-409.
77. 77. Wonnacott S., Drasdo A., Sanderson E. and Rowell P. (1990) Presynaptic nicotinic receptors and the modulation of transmitter release. Ciba Found. Symp. 152, 87-101.
78. 78. Zoli M., Zini I., Agnati L. F., Guidolin L., Ferraguti D. and Fuxe K. (1990) Aspects of neuronal plasticity in the central nervous system. I. Computer-assisted image analysis methods. Neurochem. Int. 16, 383-418.